2nd Quarter - Report
PIER STRATEGIES LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to health care reform and biogenerics legislation. Budget and appropriations issues. Import safety legislation.
Foreign entity interest: Per LD-1 Form, line 14. Teva Pharmaceuticals Ltd. - amt of contribution for lobbying activities, $0.00 ownership, 100% Teva Pharmaceuticals Europe B.V. - same details as above
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID SCHWARZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.